• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Humana Inc.

    4/16/26 5:05:06 PM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email
    S-8 1 dp245157_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on April 16, 2026

     

    Registration No. 333-

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM S-8 

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

     

    HUMANA INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   61-0647538
    (State or Other Jurisdiction of
    Incorporation or Organization)
      (I.R.S. Employer
    Identification No.)

     

    101 East Main Street

    Louisville, Kentucky 40202

    (502) 580-1000 

    (Address of Principal Executive Offices) (Zip Code)

     

    Humana Inc. 2026 Stock Incentive Plan

    (Full Title of the Plan)

     

     

    Joseph C. Ventura

    Chief Legal Officer

    Humana Inc.

    101 East Main Street

    Louisville, Kentucky 40202

    (502) 580-1000 

    (Telephone Number, including area code, of agent for service)

     

     

     

    Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

                 
    Large accelerated filer   ☒   Accelerated filer   ☐
           
    Non-accelerated filer   ☐   Smaller reporting company   ☐
           
            Emerging growth company   ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     

     

    PART I

     

    INFORMATION REQUIRED IN THIS PROSPECTUS

     

    The information specified in Item 1 and Item 2 of Part I of Form S-8 is omitted from this Registration Statement on Form S-8 (this “Registration Statement”) in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the introductory note to Part I of the Form S-8 instructions. The documents containing the information specified in Part I will be delivered to the participants in the plans as required by Rule 428(b)(1).

     

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3. Incorporation of Documents by Reference. 

     

    The following documents filed by the Registrant with the Commission pursuant to the Securities Act, and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are incorporated herein by reference:

     

    (a)     the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (File No. 001-05975), filed with the Securities and Exchange Commission (the “Commission”) on February 19, 2026;
     
    (b)    all other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Registrant’s Annual Report referred to in (a) above; and
     
    (c)     the description of the Registrant’s common stock, par value $0.16-2/3 per share, contained in the Registrant’s Registration Statement on Form 8-A/A filed with the Commission on March 1, 1999 (File No.
    001-05975).

     

    All documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the filing of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing such documents, except as to specific sections of such documents as set forth therein. Unless expressly incorporated into this Registration Statement, a report furnished on Form 8-K prior or subsequent to the filing of this Registration Statement shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document that also is deemed to be incorporated by reference herein modifies or supersedes such statement.

     

    Item 4. Description of Securities.

     

    Not applicable.

     

    Item 5. Interests of Named Experts and Counsel.

     

    The validity of the issuance of the shares of Common Stock being offered by the Registration Statement will be passed upon for the Registrant by Joseph C. Ventura, Chief Legal Officer of the Registrant. As of April 1, 2026, Mr. Ventura owned 10,837 shares of Common Stock of the Registrant (the “Common Stock”), has the equivalent of 293 shares of Common Stock in the Humana Retirement and Savings Plan, holds restricted stock units with respect to 6,250 shares of Common Stock and also has exercisable stock options to purchase 21,729 shares of Common Stock .

     

     

     

    Item 6. Indemnification of Directors and Officers.

     

    The Registrant’s Restated Certificate of Incorporation and amended and restated by-laws include provisions to (i) eliminate the personal liability of its directors and officers for monetary damages resulting from breaches of their fiduciary duty to the extent permitted by Section 102(b)(7) of the General Corporation Law of Delaware (the “Delaware Law”) and (ii) authorize the Registrant to indemnify its directors and officers to the fullest extent permitted by Section 145 of the Delaware Law, including circumstances in which indemnification is otherwise discretionary.

     

    Pursuant to Section 145 of the Delaware Law, a corporation generally has the power to indemnify its present and former directors, officers, employees and agents against expenses incurred by them in connection with any suit to which they are, or are threatened to be made, a party by reason of their serving in such positions so long as they acted in good faith and in a manner they reasonably believed to be in, or not opposed to, the best interests of a corporation, and with respect to any criminal action, they had no reasonable cause to believe their conduct was unlawful. The Registrant believes that these provisions are necessary to attract and retain qualified persons as directors and officers. These provisions do not eliminate liability for breach of the director’s duty of loyalty to the Registrant or its stockholders, for acts or omissions not in good faith or involving intentional misconduct or knowing violations of law, for any transaction from which the director derived an improper personal benefit or for any willful or negligent payment of any unlawful dividend or any unlawful stock purchase or redemption.

     

    The Registrant has entered into agreements with its directors and executive officers that require the Registrant to indemnify such persons against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred (including expenses of a derivative action) in connection with any proceeding, whether actual or threatened, to which any such person may be made a party by reason of the fact that such person is or was a director or officer of the Registrant or any of its affiliates, provided such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Registrant and, with respect to any criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful. The indemnification agreements also set forth certain procedures that will apply in the event of a claim for indemnification thereunder.

     

    See also the Undertakings set forth in the response to Item 9 herein.

     

    Item 7. Exemption for Registration Claimed.

     

    Not applicable.

     

    Item 8. Exhibits. 

     

     

     

    Exhibit       Incorporated by Reference   Filed
    Number   Exhibit Description   Form   File No.   Exhibit   Filing Date   Herewith
                 
    4.1   Restated Certificate of Incorporation of Humana Inc. filed with the Secretary of State of Delaware on November 9, 1989, as restated to incorporate the amendment of January 9, 1992, and the correction of March 23, 1992, and the amendment dated April 24, 2024     10-Q for quarter ended June 30, 2024   033-05975   3(i)   July 31, 2024    
                 
    4.2   Humana Inc. Amended and Restated By-laws, effective as of December 7, 2023   8-K   001-05975   3(b)   December 7, 2023    
                 
    4.3   Form of Registrant’s Common Stock certificate   8-A/A   001-05975   4.3   March 1, 1999    
                 
    5.1   Opinion of counsel as to the validity of the securities registered herein                   X
                 
    23.1   Consent of PriceWaterhouseCoopers LLP, independent registered public accounting firm for the Registrant                   X
                 
    23.2   Consent of counsel (included in the opinion filed as Exhibit 5.1)                   X
                 
    99.1   Humana Inc. 2026 Stock Incentive Plan                   X
                 
    107   Filing Fee Table                   X

     

    Item 9. Undertakings.

     

    (a)The undersigned Registrant hereby undertakes:

     

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

     

      (i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

     

      (ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Table” set forth in Exhibit 107 to this Registration Statement;

     

      (iii) To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

     

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

     

     

     

    (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, hereunto duly authorized, in the city of Louisville, Commonwealth of Kentucky, on April 16, 2026.

     

     

    HUMANA INC.
     
    /s/ Celeste M. Mellet

    Celeste M. Mellet

    Chief Financial Officer

     

     

     

    POWER OF ATTORNEY

     

    Each person whose signature appears below constitutes and appoints James A. Rechtin, Celeste M. Mellet and John-Paul W. Felter, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution to execute in his or her name and on his or her behalf, and to file any amendments (including, without limitation, post-effective amendments) to this Registration Statement necessary or advisable in the opinion of any of them to enable the Company to comply with the Securities Act, and any rules, regulations and requirements of the Securities and Exchange Commission thereunder, in connection with the registration of the additional securities which are under the subject of this Registration Statement.

     

    Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated below.

     

     

     

             
    Signature   Title   Date
         
    /s/ Celeste M. Mellet   Chief Financial Officer   April 16, 2026
    Celeste M. Mellet   (Principal Financial Officer)    
         

    /s/ John-Paul W. Felter
      Senior Vice President,
    Chief Accounting Officer and Controller
      April 16, 2026
    John-Paul W. Felter   (Principal Accounting Officer)    
         

    /s/ James A. Rechtin
      President and Chief Executive Officer,
    Director
      April 16, 2026
    James A. Rechtin   (Principal Executive Officer)    
         
    /s/ Kurt J. Hilzinger   Chairman of the Board   April 16, 2026
    Kurt J. Hilzinger        
         
    /s/ Raquel C. Bono, M.D.   Director   April 16, 2026
    Raquel C. Bono, M.D.        
         
    /s/ Frank A. D’Amelio   Director   April 16, 2026
    Frank A. D’Amelio        
         
    /s/ David T. Feinberg, M.D.   Director   April 16, 2026
    David T. Feinberg, M.D.        
             
    /s/ Robert S. Field   Director   April 16, 2026
    Robert S. Field        
         
    /s/ Wayne A. I. Frederick, M.D.   Director   April 16, 2026
    Wayne A. I. Frederick, M.D.        
         
    /s/ Karen W. Katz   Director   April 16, 2026
    Karen W. Katz        
         
    /s/ Marcy S. Klevorn   Director   April 16, 2026
    Marcy S. Klevorn        
         
    /s/ Jorge S. Mesquita   Director   April 16, 2026
    Jorge S. Mesquita        
             
    /s/ Gordon Smith   Director   April 16, 2026
    Gordon Smith        

     

     

    Get the next $HUM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    2/12/2026$189.00Outperform → Sector Perform
    RBC Capital Mkts
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    12/5/2025$313.00Hold → Buy
    Jefferies
    10/14/2025$235.00Sell
    Goldman
    9/22/2025$295.00In-line
    Evercore ISI
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    More analyst ratings

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Humana from Outperform to Sector Perform and set a new price target of $189.00

    2/12/26 8:16:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00

    2/2/26 6:49:06 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Humana from Overweight to Equal Weight and set a new price target of $290.00

    1/7/26 8:56:48 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, CenterWell Shetty Sanjay K bought $150,016 worth of Humana Common (810 units at $185.21), increasing direct ownership by 7% to 11,657 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 11:48:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 31, 2026 to stockholders of record as of the close of business on June 26, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Le

    4/15/26 5:00:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    On the Line for Lung Health: Telephone Training Helps COPD Patients Perfect Inhaler Use

    Humana Healthcare Research and University of Chicago Medicine study highlights promise of improving respiratory care through remote learning. A new study published in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation shows how an innovative phone-based inhaler education program helped Medicare Advantage beneficiaries with COPD use their inhalers more effectively. Researchers from Humana Healthcare Research and University of Chicago Medicine (UChicago Medicine) found that Humana members with COPD and low medication adherence who participated in the program in 2020 significantly improved their inhaler technique after receiving guidance over the phone from pharmaci

    4/15/26 10:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Tuesday Health Expands National Footprint With Humana Partnership to Advance Value-Based Palliative Care

    Program launching June 1, 2026 will expand access to community-based palliative care for members living with serious illnessHOUSTON, April 14, 2026 /PRNewswire/ -- Tuesday Health today announced a new partnership with Humana Inc. (NYSE:HUM) to expand access to value-based palliative care for Texans living with serious illness, marking another step in the company's growing national footprint. Launching June 1, the program will support eligible Humana members and their caregivers with coordinated clinical guidance, proactive symptom management and ongoing support designed to improve quality of life and help members receive care aligned with their individual goals.

    4/14/26 9:19:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    SEC Filings

    View All

    SEC Form S-8 filed by Humana Inc.

    S-8 - HUMANA INC (0000049071) (Filer)

    4/16/26 5:05:06 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    4/10/26 4:32:11 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    3/9/26 4:22:23 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Shetty Sanjay K

    4 - HUMANA INC (0000049071) (Issuer)

    4/3/26 10:48:44 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Renaudin George Ii

    4 - HUMANA INC (0000049071) (Issuer)

    4/2/26 11:18:30 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Hilzinger Kurt J

    4 - HUMANA INC (0000049071) (Issuer)

    4/2/26 9:45:57 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Financials

    Live finance-specific insights

    View All

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 31, 2026 to stockholders of record as of the close of business on June 26, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Le

    4/15/26 5:00:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. to Release First Quarter 2026 Results on April 29, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 1Q26 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BId1413c4c078343e28841e18c372f7b58.

    3/30/26 4:30:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 24, 2026 to stockholders of record as of the close of business on March 27, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large.

    2/19/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/14/24 10:02:59 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/13/24 5:06:27 PM ET
    $HUM
    Medical Specialities
    Health Care